The cells assigned to prime CD8 T cells are mainly tumor-infiltrating dendritic cells (DCs) that can scan and phagocytize tumor cells, process tumor-associated antigens, and present antigen-derived peptides within HLA class II molecules. This evidence concerns the gene CD8A and neoplasm.